Insight

Florian Lordick: Latest Real World Data on Biomarker Testing for Patients with Gastric Cancer

Florian Lordick/LinkedIn

May 1, 2025, 00:45

Florian Lordick: Latest Real World Data on Biomarker Testing for Patients with Gastric Cancer

Florian Lordick, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn:

“Happy to share latest Real World Data on Biomarker testing for patients with Gastric Cancer in clinical routine and in the Leipzig Pathology. Results of the Saphir Study, published by Karin Potthoff et al. in ESMO – European Society for Medical Oncology Real World Data and Digital Oncology journal.”

“Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry”

Authors: K. Potthoff, H. Bläker, T. Dechow, A. Binninger, K. Ringwald, R. de Buhr, E. von der Heyde, M.-O. Zahn, A. Nusch, S. Dörfel, H. Schulz, I. Haffner, A.K. Höhn, A. Monecke, S. Lorenzen, A. Reinacher-Schick, M. Jänicke, F. Lordick

You Can Read the Full Article in Real World Data and Digital Oncology journal.

Florian Lordick

More posts featuring Florian Lordick.

A. Binninger A. Monecke A. Nusch A. Reinacher-Schick A.K. Höhn cancer E. von der Heyde F. Lordick Florian Lordick gastric cancer H. Bläker H. Schulz I. Haffner K. Potthoff K. Ringwald M. Jänicke M.-O. Zahn OncoDaily Oncology R. de Buhr S. Dörfel S. Lorenzen T. Dechow

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology